Coronavirus LIVE: Russia's Covid-19 vaccine over 91% effective, says study
Coronavirus LIVE updates: Globally, nearly 104 million people have been infected by the virus and the death toll stands at 2,247,005
Delhi records 2 Covid-19 deaths, lowest in 10 months
The national capital reported 114 fresh COVID-19 cases and two deaths due to the disease on Tuesday, the lowest in around 10 months, authorities said. The death toll stood at 10,858, while the cumulative COVID-19 case count rose to 6,35,331, they said. The 114 cases came out of 58,598 tests, including 31,159 RT-PCR and 27,439 rapid antigen ones, conducted the previous day for detection of COVID-19, according to a bulletin issued by the Delhi Health Department.
The tally of active cases has dropped to 1,217 from 1,265 on Monday, the bulletin said, adding that 6,23,256 patients have recovered, been discharged or migrated so far. According to the bulletin, 5,684 beds out of the total 6,305 in the city's COVID-19 hospitals are vacant. The number of people in home isolation dropped to 466 from 504 on Monday.
Earlier in the day, Health Minister Satyendar Jain said56.13 per cent of those covered under the latest serological survey in the city in January have developed antibodies against coronavirus.
Rajasthan reports 87 new Covid-19 cases, 235 recoveries
Delhi reports 114 new Covid-19 cases, 160 recoveries
395 new Covid-19 cases in Karnataka, 412 recoveries
Maharashtra records 1,927 new Covid-19 cases, 4,011 recoveries, 30 deaths
512 train passengers in Mumbai fined for not wearing masks
UK variant of Covid-19 has mutated again: Scientists
Over 80 people arrested in China for smuggling fake Covid-19 vaccines
PM-CARES Fund to foot over 80% cost of 1st phase of Covid vaccination drive
Russia's Covid-19 vaccine shows over 91% efficacy in phase 3 trial: Lancet study
The findings are based on analysis of data from nearly 20,000 participants, three-quarters of whom received the two-dose regimen of the adenovirus-based vaccine, Gam-COVID-Vac, and one quarter received a placebo. Serious adverse events or those requiring hospital admission were rare in both the placebo and vaccine groups and none were considered associated with vaccination, the researchers said.
Supply order for Covishield was placed after drug regulator's nod: Govt
Covishield is being manufactured by the Pune-based firm with technology transfer from AstraZeneca/Oxford University. READ ON...
80.10% of the daily new cases are from 6 States and UTs: Health Ministry
No data generated with Covishield, Covaxin on 'European' strain of coronavirus, Rajya Sabha told
Coronavirus LIVE: 56.13% people in Delhi have antibodies against Covid-19
US Democrats file budget resolution for Covid-19 relief
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 02 2021 | 8:33 AM IST